{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T09:53:48Z","timestamp":1777542828044,"version":"3.51.4"},"reference-count":64,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Clin Pathol"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1309\/jwl27grgu71vp5ql","type":"journal-article","created":{"date-parts":[[2007,3,30]],"date-time":"2007-03-30T20:20:34Z","timestamp":1175286034000},"page":"68-75","source":"Crossref","is-referenced-by-count":37,"title":["Obstetric Complications in Patients with Hereditary Thrombophilia Identified Using the LCx Microparticle Enzyme Immunoassay"],"prefix":"10.1093","volume":"127","author":[{"given":"Olivier","family":"Kocher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Cirovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Malynn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles M.","family":"Rowland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lance A.","family":"Bare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradford A.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry G.","family":"Henslee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas G.","family":"Laffler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey B.","family":"Huff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margot S.","family":"Kruskall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth A.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2007,1,1]]},"reference":[{"key":"E00001","unstructured":"Sibai BM. Thrombophilias and adverse outcomes of pregnancy: what should a clinician do [editorial]? <i>N Engl J Med.<\/i> 1999;340:50-52."},{"key":"E00002","doi-asserted-by":"crossref","unstructured":"Arias E. Annual summary of vital statistics, 2002. <i>Pediatrics<\/i>. 2003;112:1215-1230.","DOI":"10.1542\/peds.112.6.1215"},{"key":"E00003","unstructured":"Gerhardt A, Sharf R, Bechmann M, et al. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. <i>N Engl J Med.<\/i> 2000;342:374-380."},{"key":"E00004","doi-asserted-by":"crossref","unstructured":"Martinelli I, de Stefano V, Taioli E, et al. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium. <i>Thromb Haemost<\/i>. 2002;87:791-795.","DOI":"10.1055\/s-0037-1613085"},{"key":"E00005","unstructured":"Many A, Schreiber L, Rosner S, et al. Pathologic features of the placenta in women with severe pregnancy complications and thrombophilia. <i>Obstet Gynecol.<\/i> 2001;98:1041-1044."},{"key":"E00006","unstructured":"Arias E, Romero R, Joist H, et al. Thrombophilia: a mechanism of disease in women with adverse pregnancy outcome and thrombotic lesions of the placenta. <i>J Matern Fetal Med.<\/i> 1998;7:277-286."},{"key":"E00007","unstructured":"Simioni P, Prandoni P, Lensing A, et al. The risk of recurrent venous thromboembolism in patients with Arg506-Gln mutations in the gene for factor V (factor V Leiden). <i>N Engl J Med.<\/i> 1997;336:399-403."},{"key":"E00008","unstructured":"Juul K, Tybjaerg-Hansen A, Schnohr P, et al. Factor V Leiden. <i>Intern Med.<\/i> 2004;140:330-337."},{"key":"E00009","doi-asserted-by":"crossref","unstructured":"Poort SR, Rosendaal FR, Reitsma PH, et al. A common genetic variation in the 3'-ultranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. <i>Blood<\/i>. 1996;88:3698-3703.","DOI":"10.1182\/blood.V88.10.3698.bloodjournal88103698"},{"key":"E00010","unstructured":"Ferraresi P, Marchetti C, Legnani C, et al. The heterozygous 20210 G\/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilia and is not increased in frequency in artery disease. <i>Arterioscler Thromb Vasc Biol.<\/i> 1997;17:2418-2422."},{"key":"E00011","doi-asserted-by":"crossref","unstructured":"Bertina R, Koeleman B, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. <i>Nature<\/i>. 1994;369:64-67.","DOI":"10.1038\/369064a0"},{"key":"E00012","doi-asserted-by":"crossref","unstructured":"Ceelie H, Spaargaren van Niel C, Bertina R, et al. G20210A is a functional mutation in the prothrombin gene: effects on protein levels and 3'-end formation. <i>J Thromb Haemost<\/i>. 2004;2:119-127.","DOI":"10.1111\/j.1538-7836.2003.00493.x"},{"key":"E00013","unstructured":"Sachchithananthan M, Stasinopoulos S, Wilusz F, et al. The relationship between the prothrombin upstream sequence element and the G20210A polymorphism: the influence of a competitive environment for mRNA 3'-end formation. <i>Nucleic Acids Res.<\/i> 2005;33:1010-1020."},{"key":"E00014","doi-asserted-by":"crossref","unstructured":"Bertina R. Molecular risk factors for thrombosis. <i>Thromb Haemost<\/i>. 1999;82:601-609.","DOI":"10.1055\/s-0037-1615886"},{"key":"E00015","unstructured":"Ridker P, Miletich J, Buring J, et al. Factor V Leiden mutation as a risk factor for recurrent pregnancy loss. <i>Ann Intern Med.<\/i> 1998;128:1000-1003."},{"key":"E00016","unstructured":"Kupperminc MJ, Eldor A, Steinman N, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. <i>N Engl J Med.<\/i> 1999;340:9-13."},{"key":"E00017","unstructured":"Martinelli I, Taioli E, Cetin I, et al. Mutations in coagulation factors in women with unexplained late fetal loss. <i>N Engl J Med.<\/i> 2000;343:1015-1018."},{"key":"E00018","doi-asserted-by":"crossref","unstructured":"Rey E, Kahn S, David M, et al. Thrombophilic disorders and fetal loss: a meta-analysis. <i>Lancet<\/i>. 2003;361:901-908.","DOI":"10.1016\/S0140-6736(03)12771-7"},{"key":"E00019","doi-asserted-by":"crossref","unstructured":"Dudding T, Attia J. The association between adverse pregnancy outcomes and maternal factor V Leiden genotype: a meta-analysis. <i>Thromb Haemost<\/i>. 2004;91:700-711.","DOI":"10.1160\/TH03-10-0637"},{"key":"E00020","unstructured":"Lin J, August P. Genetic thrombophilias and preeclampsia: a meta-analysis. <i>Obstet Gynecol.<\/i> 2005;105:182-192."},{"key":"E00021","unstructured":"Howley H, Walker M, Rodger M. A systematic review of the association between factor V Leiden or prothrombin gene variant and intrauterine growth restriction. <i>Am J Obstet Gynecol.<\/i> 2005;192:694-708."},{"key":"E00022","unstructured":"Rai R, Shlebak A, Cohen H, et al. Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage. <i>Hum Reprod.<\/i> 2001;16:961-965."},{"key":"E00023","unstructured":"Alfirevic Z, Mousa H, Martlew V, et al. Postnatal screening for thrombophilia in women with severe pregnancy complications. <i>Obstet Gynecol.<\/i> 2001;97:753-759."},{"key":"E00024","unstructured":"Livingston J, Barton J, Park V, et al. Maternal and fetal inherited thrombophilia are not related to the development of severe preeclampsia. <i>Am J Obstet Gynecol.<\/i> 2001;185:153-157."},{"key":"E00025","unstructured":"Gonen R, Lavi N, Attias D, et al. Absence of association of inherited thrombophilia with unexplained third-trimester intrauterine fetal death. <i>Am J Obstet Gynecol.<\/i> 2005;192:742-746."},{"key":"E00026","unstructured":"American College of Obstetricians and Gynecologists. <i>Compendium of Selected Publications<\/i>. Washington, DC: American College of Obstetricians and Gynecologists; 2001:179-182, 401-408, 425-431, 950-960."},{"key":"E00027","unstructured":"Cunningham F, Gant N, Leveno K, et al. <i>Williams Obstetrics<\/i>. New York, NY: McGraw-Hill; 2001:569-570."},{"key":"E00028","unstructured":"Hunault M, Marsh-Scott C, Jou C, et al. Automated detection of the factor V Leiden mutation using the LCx microparticle enzyme immunoassay. <i>Clin Chem.<\/i> 1999;45:41-46."},{"key":"E00029","unstructured":"Gilchrist A, Solomon N, Erickson D, et al. Automated detection of the G20210A prothrombin mutation using the LCx microparticle enzyme immunoassay. <i>Clin Chim Acta.<\/i> 2001;314:249-254."},{"key":"E00030","unstructured":"Ridker P, Hennenkens C, Lindpaintner K, et al. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. <i>N Engl J Med.<\/i> 1995;332:912-917."},{"key":"E00031","doi-asserted-by":"crossref","unstructured":"de Stefano V, Chiusolo P, Paciaroni K, et al. Epidemiology of factor V Leiden: clinical implications. <i>Semin Thromb Hemost<\/i>. 1998;24:367-379.","DOI":"10.1055\/s-2007-996025"},{"key":"E00032","doi-asserted-by":"crossref","unstructured":"Margaglione M, Brancaccio V, de Lucia D, et al. Inherited thrombophilic risk factors and venous thromboembolism. <i>Chest<\/i>. 2000;118:1405-1411.","DOI":"10.1378\/chest.118.5.1405"},{"key":"E00033","unstructured":"Buimer M, van Doormum G, Ching S, et al. Detection of <i>Chlamydia trachomatis<\/i> and <i>Neisseria gonorrhoeae<\/i> by ligase chain reaction-based assays with clinical specimens from various sites: implication for diagnostic testing and screening. <i>J Clin Microbiol.<\/i> 1996;34:2395-2400."},{"key":"E00034","unstructured":"Birkenmeyer L, Armstrong A. Preliminary evaluation of the ligase chain reaction for detection of <i>Neisseria gonorrhoeae. J Clin Microbiol.<\/i> 1992;30:3089-3094."},{"key":"E00035","doi-asserted-by":"crossref","unstructured":"Marshall RL, Cockerill J, Friedman P, et al. Detection of GB virus C by the RT-PCR LCx System. <i>J Virol Methods<\/i>. 1998;73:99-107.","DOI":"10.1016\/S0166-0934(98)00050-0"},{"key":"E00036","unstructured":"McGlennen R, Key N. Clinical and laboratory management of the prothrombin G20210A mutation. <i>Arch Pathol Lab Med.<\/i> 2002;126:1319-1325."},{"key":"E00037","unstructured":"Meinardi J, Middeldorp S, de Kam P, et al. Increased risk for fetal loss in carriers of the factor V Leiden mutation. <i>Ann Intern Med.<\/i> 1999;130:736-739."},{"key":"E00038","doi-asserted-by":"crossref","unstructured":"Preston F, Rosendaal F, Walker I, et al. Increased fetal loss in women with heritable thrombophilia. <i>Lancet<\/i>. 1996;348:913-916.","DOI":"10.1016\/S0140-6736(96)04125-6"},{"key":"E00039","doi-asserted-by":"crossref","unstructured":"Volzke H, Grimm R, Robinson D, et al. Factor V Leiden and the risk of stillbirth in a German population. <i>Thromb Haemost<\/i>. 2003;90:429-433.","DOI":"10.1160\/TH03-02-0117"},{"key":"E00040","doi-asserted-by":"crossref","unstructured":"Hefler L, Jirecek S, Heim K, et al. Genetic polymorphisms associated with thrombophilia and vascular disease in women with unexplained late intrauterine fetal death: a multicenter study. <i>J Soc Gynecol Investig<\/i>. 2004;11:42-44.","DOI":"10.1016\/j.jsgi.2003.07.008"},{"key":"E00041","doi-asserted-by":"crossref","unstructured":"Kupferminc M, Peri H, Zwang E, et al. High prevalence of the prothrombin gene mutation in women with intrauterine growth retardation, abruptio placentae and second trimester loss. <i>Acta Obstet Gynecol Scand<\/i>. 2000;79:963-967.","DOI":"10.1034\/j.1600-0412.2000.079011963.x"},{"key":"E00042","unstructured":"Agorastos T, Karavida A, Lambropoulos A, et al. Factor V Leiden and prothrombin G20210A mutations in pregnancies with adverse outcome. <i>J Matern Fetal Neonatal Med.<\/i> 2002;12:267-273."},{"key":"E00043","unstructured":"Many A, Elad R, Yaron Y, et al. Third-trimester unexplained intrauterine fetal death is associated with inherited thrombophilia. <i>Obstet Gynecol<\/i>. 2002;99:684-687."},{"key":"E00044","unstructured":"van Dunne F, Doggen C, Heemskerk M, et al. Factor V Leiden mutation in relation to fecundity and miscarriage in women with venous thrombosis. <i>Hum Reprod.<\/i> 2005;20:802-806."},{"key":"E00045","unstructured":"Ghee C, Burrows R. Prothrombin G20210A mutation is not associated with recurrent miscarriages. <i>Aust N Z J Obstet Gynaecol.<\/i> 2002;42:167-169."},{"key":"E00046","unstructured":"Kim Y, Williamson R, Murray J, et al. Genetic susceptibility to preeclampsia: roles of cytosine-to-thymine substitution at nucleotide 677 of the gene for methylenetetrahydrofolate reductase, 68-base pair insertion at nucleotide 844 of the gene for cystathionine \u03b2-synthase, and factor V Leiden mutation. <i>Am J Obstet Gynecol.<\/i> 2001;184:1211-1217."},{"key":"E00047","doi-asserted-by":"crossref","unstructured":"Morrison E, Miedzybrodzka Z, Campbell D, et al. Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review. <i>Thromb Haemost<\/i>. 2002;87:779-785.","DOI":"10.1055\/s-0037-1613083"},{"key":"E00048","doi-asserted-by":"crossref","unstructured":"Carp H, Salomon O, Seidman D, et al. Prevalence of genetic markers for thrombophilia in recurrent pregnancy loss. 2002;17:1633-1637.","DOI":"10.1093\/humrep\/17.6.1633"},{"key":"E00049","unstructured":"Reznikoff-Etievant M, Cayol V, Carbonne B, et al. Factor V Leiden and G20210A prothrombin mutations are risk factors for very early recurrent miscarriage. <i>Br J Obstet Gynaecol.<\/i> 2001;108:1251-1254."},{"key":"E00050","unstructured":"Finan R, Tamim H, Ameen G, et al. Prevalence of factor V G1691A (factor V Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population. <i>Am J Hematol.<\/i> 2002;71:300-305."},{"key":"E00051","unstructured":"Anteby EY, Musalam B, Milwidsky A, et al. Fetal inherited thrombophilias influence the severity of preeclampsia, IUGR and placental abruption. <i>Eur J Obstet Gynecol Reprod Biol.<\/i> 2004;113:31-35."},{"key":"E00052","doi-asserted-by":"crossref","unstructured":"Verspyck E, Le Cam-Duchez V, Goffinet F, et al. Thrombophilia and immunological disorders in pregnancies as risk factors for small for gestational age infants. <i>Br J Obstet Gynaecol<\/i>. 2002;109:28-33.","DOI":"10.1111\/j.1471-0528.2002.00411.x"},{"key":"E00053","doi-asserted-by":"crossref","unstructured":"Gopel W, Kim D, Gortner L. Prothrombotic mutations as a risk factor for preterm birth [letter]. <i>Lancet<\/i>. 1999;353:1411-1412.","DOI":"10.1016\/S0140-6736(99)00665-0"},{"key":"E00054","doi-asserted-by":"crossref","unstructured":"Hao K, Wang X, Niu T, et al. A candidate gene association study on preterm delivery: application of high-throughput genotyping technology and advanced statistical methods. <i>Hum Mol Genet<\/i>. 2004;13:683-691.","DOI":"10.1093\/hmg\/ddh091"},{"key":"E00055","unstructured":"Riyazi N, Leeda M, de Vries J, et al. Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study. <i>Eur J Obstet Gynecol Reprod Biol.<\/i> 1998;80:49-54."},{"key":"E00056","doi-asserted-by":"crossref","unstructured":"Brenner B, Hoffman R, Blumenfeld Z, et al. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin. <i>Thromb Haemost<\/i>. 2000;83:693-697.","DOI":"10.1055\/s-0037-1613894"},{"key":"E00057","unstructured":"Younis JS, Ohel G, Brenner B, et al. The effect of thrombophylaxis on pregnancy outcome in patients with recurrent pregnancy loss associated with factor V Leiden mutation. <i>BJOG.<\/i> 2000;107:415-419."},{"key":"E00058","doi-asserted-by":"crossref","unstructured":"Kupferminc M, Fait G, Many A, et al. Low-molecular-weight heparin for the prevention of obstetric complications in women with thrombophilias. <i>Hypertens Pregnancy<\/i>. 2001. 20:35-44.","DOI":"10.1081\/PRG-100104170"},{"key":"E00059","doi-asserted-by":"crossref","unstructured":"Grandone E, Brancaccio V, Colaizzo D, et al. Preventing adverse obstetric outcomes in women with genetic thrombophilia. <i>Fertil Steril<\/i>. 2002;78:371-375.","DOI":"10.1016\/S0015-0282(02)03222-3"},{"key":"E00060","unstructured":"Lindqvist P, Olofsson P, Dahlback B. Use of selective factor V Leiden screening in pregnancy to identify candidates for anticoagulants. <i>Obstet Gynecol.<\/i> 2002;100:332-336."},{"key":"E00061","unstructured":"Tzafettas J, Mamopoulos A, Anapliotis A, et al. Thromboprophylaxis throughout pregnancy in women with previous history of recurrent miscarriages of unknown aetiology. <i>Clin Exp Obstet Gynecol.<\/i> 2002;29:267-270."},{"key":"E00062","doi-asserted-by":"crossref","unstructured":"Carp H, Dolitzky M, Inbal A. Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia. <i>J Thromb Haemost<\/i>. 2003;1:433-438.","DOI":"10.1046\/j.1538-7836.2003.00066.x"},{"key":"E00063","doi-asserted-by":"crossref","unstructured":"Gris J, Mercier E, Quere I, et al. Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. <i>Blood<\/i>. 2004;103:3695-3699.","DOI":"10.1182\/blood-2003-12-4250"},{"key":"E00064","unstructured":"Grody W, Griffin J, Taylor A, et al. American College of Medical Genetics consensus statement on factor V Leiden mutation testing. <i>Genet Med.<\/i> 2001;3:139-148."}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/127\/1\/68\/4988643\/ajcpath127-0068.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T14:50:49Z","timestamp":1707749449000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article-lookup\/doi\/10.1309\/JWL27GRGU71VP5QL"}},"subtitle":["A Controlled Study of 5,000 Patients"],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":64,"aliases":["10.1309\/j64r-8020-2j71-2k80"],"journal-issue":{"issue":"1","published-online":{"date-parts":[[2007,1,1]]},"published-print":{"date-parts":[[2007,1]]}},"alternative-id":["10.1309\/JWL27GRGU71VP5QL"],"URL":"https:\/\/doi.org\/10.1309\/jwl27grgu71vp5ql","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"value":"0002-9173","type":"print"},{"value":"1943-7722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}